Abstract
Clinical evidence highlights the important role of Cell surface transmembrane glycoprotein CD200 receptor 1 (CD200R1) in experimental autoimmune diseases. So, we conducted this study to evaluate variations of CD200R1 in rheumatoid arthritis.